Bolt Biotherapeutics's common stock is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Bolt Biotherapeutics (BOLT) currently reports a common stock of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bolt Biotherapeutics's common stock history and peer comparisons.
Bolt Biotherapeutics's common stock changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bolt Biotherapeutics reported $0 in common stock as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bolt Biotherapeutics, and consider following BOLT for alerts when major investors trade the stock.
Bolt Biotherapeutics is classified in the Healthcare sector. On common stock, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BOLT with unrelated industries.